Literature DB >> 34755676

[Diffusion-weighted magnetic resonance imaging instead of contrast-enhanced imaging for evaluating immediate therapeutic efficacy of high-intensity focused ultrasound ablation of adenomyosis].

Y Cui1, L Yao1, M Feng2, J Zhang1, D Zhang1.   

Abstract

OBJECTIVE: To explore the feasibility of diffusion-weighted magnetic resonance imaging (DWI) instead of contrast-enhanced (CE) imaging for evaluation of the immediate therapeutic efficacy of high-intensity focused ultrasound (HIFU) ablation for treatment of adenomyosis.
METHODS: We retrospectively analyzed the data of 29 patients aged 40.5 ± 5.4 years under going HIFU treatment for adenomyosis in our hospital between December, 2017 and July, 2020. The patients received MRI examination both before and within 24 h after the operation. Two observers analyzed the morphology of the ablation area on DWI and classified the lesions into type 1 (spot-like or no obvious signal intensity changes), type 2 (patchy signal intensity changes) and type 3 (ring-like signal intensity changes). The inter- and intra-observer reliability of morphological assessment was assessed using kappa test. The volume of necrotic tissues following the ablation was measured with both DWI and CE imaging, and the consistency of the measurements and the inter- and intra-observer reliability of DWI-based measurements were evaluated using Bland-Altman plot tests.
RESULTS: The median volume of necrotic tissues was 36.9 cm3 (range 16.4-65.5 cm3) following ablation of the 29 lesions. DWI findings identified 24-25 (82.8%-86.2%) lesions with type 2 or 3 signal changes following the ablation with measurable necrotic tissue volume. On DW images, the Kappa value of intra- and inter-observer reliability for morphological classification of the ablation area reached 0.798 (P=0.000) and 0.933 (P= 0.000), respectively. Bland-Altman plots showed a good consistency of the necrotic volumes measured by CE and at DWI with a strong inter- and intra-observer reliability of DWI-based volume measurements (with only one point outside the range of 95% limits of agreement). The remaining 4 or 5 lesions, which presented with type 1 signal changes following ablation, were all small in size (the largest was only 18.61 cm3) and showed poor therapeutic responses to the ablation.
CONCLUSION: DWI-based morphological assessment and necrotic tissue volume measurement can replace CE imaging for assessment of the immediate therapeutic efficacy of HIFU ablation for treatment of adenomyosis.

Entities:  

Keywords:  adenomyosis; diffusion-weighted magnetic resonance imaging; high-intensity focused ultrasound ablation; magnetic resonance imaging

Mesh:

Year:  2021        PMID: 34755676      PMCID: PMC8586868          DOI: 10.12122/j.issn.1673-4254.2021.10.19

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  16 in total

1.  T2*-weighted imaging in the assessment of the non-perfused volume of uterine fibroids following magnetic resonance-guided high-intensity focused ultrasound ablation.

Authors:  Jing Liu; Juan Wei; Bilgin Keserci; Jianhua Zhang; Xuedong Yang; Xiaoying Wang
Journal:  Int J Gynaecol Obstet       Date:  2015-10-03       Impact factor: 3.561

Review 2.  Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: A review of safety and efficacy.

Authors:  Lian Zhang; Wenyi Zhang; Franco Orsi; Wenzhi Chen; Zhibiao Wang
Journal:  Int J Hyperthermia       Date:  2015-01-22       Impact factor: 3.914

Review 3.  Minimally invasive treatment of adenomyosis.

Authors:  Margit Dueholm
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2018-02-15       Impact factor: 5.237

4.  Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Circ J       Date:  2019-11-11       Impact factor: 2.993

5.  Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.

Authors:  Tomonori Kanda; Toshio Fukusato; Megumi Matsuda; Keiko Toyoda; Hiroshi Oba; Jun'ichi Kotoku; Takahiro Haruyama; Kazuhiro Kitajima; Shigeru Furui
Journal:  Radiology       Date:  2015-05-05       Impact factor: 11.105

Review 6.  Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.

Authors:  Dragan Stojanov; Aleksandra Aracki-Trenkic; Daniela Benedeto-Stojanov
Journal:  Neuroradiology       Date:  2016-02-12       Impact factor: 2.804

7.  Modelling the temperature evolution of bone under high intensity focused ultrasound.

Authors:  H M M ten Eikelder; D Bošnački; A Elevelt; K Donato; A Di Tullio; B J T Breuer; J H van Wijk; E V M van Dijk; D Modena; S Y Yeo; H Grüll
Journal:  Phys Med Biol       Date:  2016-02-08       Impact factor: 3.609

8.  Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis.

Authors:  Bilgin Keserci; Nguyen Minh Duc
Journal:  Int J Hyperthermia       Date:  2018-10-11       Impact factor: 3.914

Review 9.  Bland-Altman analysis: A paradigm to understand correlation and agreement.

Authors:  Nurettin Özgür Doğan
Journal:  Turk J Emerg Med       Date:  2018-09-17

10.  The primary treatment of prostate cancer with high-intensity focused ultrasound: A systematic review and meta-analysis.

Authors:  Yue He; Ping Tan; Mingjing He; Liang Hu; Jianzhong Ai; Lu Yang; Qiang Wei
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.